When the US Food and Drug Administration (FDA) rejected Lykos Therapeutics’ new drug application for MDMA-assisted therapy last August, the initial disappointment cast a shadow over the psychedelics industry. However, the sector is seeing a resurgence of optimism in 2025 on the back of various US developments. “The psychedelic industry…
NorthStar Gaming Holdings Inc. (TSXV: BET) (OTCQB: NSBBF) (‘NorthStar’ or the ‘Company’) today announces that its principal regulator, the…
Wide Open Agriculture (WOA:AU) has announced $2.6M Placement and SPP to fast-track China entry and sales Download the PDF…
Errawarra Resources Ltd (ASX: ERW) is pleased to advise that it has awarded its inaugural drilling contract at the…
Chibougamau Copper-Gold Project, Canada HIGHLIGHTS: Gold intersected in two zones within one hole; results include: 7.4m @ 5.7g/t AuEq…
The US Federal Reserve held its third meeting of 2025 from Tuesday (May 6) to Wednesday (May 7) against…
Saga Metals Corp. (‘SAGA’ or the ‘Company’) (TSXV: SAGA) (OTCQB: SAGMF) (FSE: 20H) a North American exploration company specializing…
Lundin Mining (TSX:LUN,OTC Pink:LUNMF) has released an initial resource estimate for the Filo del Sol sulfide deposit, as well…